← Página completa de evidencia

Para obtener el resultado más limpio, desactive los encabezados y pies de página del navegador.

Dediabetes Evidence Brief

What Helps with Weight Loss in Diabetes? Evidence-Based Interventions

Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.

Informe consultado
—

Página completa de evidenciahttps://www.dediabetes.com/es/evidence/weight-loss

Resumen ejecutivo

Weight Loss evidence appears to center on Tirzepatide.

Among 167 indexed studies and 61 interventions, the strongest signals are summarized from the available evidence. Semaglutide has been studied often, while Tirzepatide appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Precaución

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Panorama de la evidencia

Estudios analizados
167
Relaciones de evidencia
100
Intervenciones
61
Resultados
7
Señales de evidencia sólida
14
Áreas de evidencia mixta
2

Hallazgos clave

  1. 01

    Across 9 studies, Semaglutide shows a consistent moderate positive signal for Body weight.

  2. 02

    Across 5 studies, Empagliflozin shows a consistent moderate positive signal for Body weight.

  3. 03

    Across 9 studies, Lifestyle intervention for prediabetes shows a consistent evidence signal for Body weight.

  4. 04

    Across 7 studies, Low-carbohydrate diet shows a consistent strong positive signal for Body weight.

Categorías de evidencia

La evidencia se organiza según la consistencia con la que respalda una conclusión y la cantidad de investigación disponible.

Intervenciones bien respaldadas

La evidencia más sólida y consistente para mejorar este resultado.

Evidence is consistently positive across multiple studies.

Por qué es importante

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretación

Tirzepatide appears to have a consistent beneficial signal in the indexed evidence.

Ejemplos principales

Tirzepatide · Low-carbohydrate diet · Liraglutide

Base de evidencia: 14 evidence pairs - 47 studies

Hallazgos que requieren una interpretación cuidadosa

Resultados que varían entre estudios o dependen de la población, el diseño, la duración o el comparador.

Some evidence is positive, but results are not consistent across all studies.

Por qué es importante

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretación

Semaglutide is mixed in the currently indexed evidence.

Precaución

Some supporting studies reported neutral, negative, or mixed findings.

Ejemplos principales

Semaglutide · Lifestyle intervention for prediabetes · Low-carbohydrate diet

Base de evidencia: 16 evidence pairs - 49 studies

Áreas de investigación emergentes

Señales positivas iniciales que requieren investigación adicional de alta calidad.

Early findings are encouraging, but stronger trials are needed.

Por qué es importante

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretación

Dipeptidyl peptidase-4 inhibitors may have a beneficial signal, but the evidence base is still developing.

Precaución

Current support is limited by study volume, RCT depth, or evidence strength.

Ejemplos principales

Dipeptidyl peptidase-4 inhibitors · Mediterranean diet · Time-Restricted Eating (TRE)

Base de evidencia: 11 evidence pairs - 18 studies

Acerca de este informe de evidencia

Este informe resume la investigación actualmente indexada por Dediabetes Evidence Intelligence. No es una guía clínica ni una recomendación médica personalizada. Las clasificaciones de evidencia pueden cambiar a medida que se indexen estudios adicionales.

Cita sugerida

—